nicotinamide mononucleotide has been researched along with Diabetic Nephropathies in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hasegawa, K; Itoh, H; Kanda, T; Kawaguchi, T; Kusahana, E; Muraoka, H; Ono, T; Sakamaki, Y; Tokuyama, H; Wakino, S; Yasuda, I | 1 |
| Hasegawa, K | 1 |
| Futatsugi, K; Hasegawa, K; Hayashi, K; Itoh, H; Kanda, T; Minakuchi, H; Muraoka, H; Naitoh, M; Sakamaki, Y; Shinozuka, K; Tokuyama, H; Umino, H; Urai, H; Wakino, S; Yoshifuji, A | 1 |
| Cha, DR; Han, JY; Han, KH; Han, SY; Kang, YS; Kim, BK; Kim, HK; Ko, GJ; Lee, MH; Park, YG; Song, HK | 1 |
2 review(s) available for nicotinamide mononucleotide and Diabetic Nephropathies
| Article | Year |
|---|---|
Novel tubular-glomerular interplay in diabetic kidney disease mediated by sirtuin 1, nicotinamide mononucleotide, and nicotinamide adenine dinucleotide Oshima Award Address 2017.
Topics: Animals; Awards and Prizes; Claudin-1; Diabetic Nephropathies; Epigenesis, Genetic; Gene Expression Regulation; Glucose Transporter Type 2; Humans; Kidney Glomerulus; Kidney Tubules; NAD; Nicotinamide Mononucleotide; Signal Transduction; Sirtuin 1; Sodium-Glucose Transporter 2 | 2019 |
Communication from Tubular Epithelial Cells to Podocytes through Sirt1 and Nicotinic Acid Metabolism.
Topics: Albuminuria; Cell Communication; Claudin-1; Diabetic Nephropathies; Epithelial Cells; Kidney Glomerulus; Kidney Tubules, Proximal; Nicotinamide Mononucleotide; Nicotinic Acids; Podocytes; Sirtuin 1 | 2016 |
2 other study(ies) available for nicotinamide mononucleotide and Diabetic Nephropathies
| Article | Year |
|---|---|
Pre-emptive Short-term Nicotinamide Mononucleotide Treatment in a Mouse Model of Diabetic Nephropathy.
Topics: Albuminuria; Animals; Claudin-1; Cytokines; Diabetic Nephropathies; Disease Models, Animal; DNA (Cytosine-5-)-Methyltransferase 1; Dose-Response Relationship, Drug; Epigenesis, Genetic; Glomerular Mesangium; Glycated Hemoglobin; Histones; Male; Mice; Mice, Knockout; NAD; Nicotinamide Mononucleotide; Nicotinamide Phosphoribosyltransferase; Nicotinamide-Nucleotide Adenylyltransferase; Podocytes; Sirtuin 1; Survival Rate; Time Factors | 2021 |
Visfatin: a new player in mesangial cell physiology and diabetic nephropathy.
Topics: Acrylamides; Adipocytes, White; Angiotensin II; Animals; Blotting, Western; Cell Survival; Cells, Cultured; Collagen Type I; Cytokines; Diabetic Nephropathies; Gene Expression; Glucose; Glucose Transporter Type 1; Mesangial Cells; Nicotinamide Mononucleotide; Nicotinamide Phosphoribosyltransferase; Phosphorylation; Piperidines; Plasminogen Activator Inhibitor 1; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Receptor, Insulin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Small Interfering; Transforming Growth Factor beta1 | 2008 |